Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 3, 2005, Pages 145-147

  Niebanck, Alison E ^a,b   Kwiatkowski, Janet L ^b   Raffini, Leslie J ^b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Absolute neutrophil count; Anti D immunoglobulin; Intravenous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW EXAMINATION; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE MEDIATED INJURY; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEUTROPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; NEUTROPENIA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; RHO(D) IMMUNE GLOBULIN;

EID: 15444380272     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000155871.26380.84     Document Type: Article

References (17)

1. Gadner H. Management of immune thrombocytopenic purpura in children. Rev Clin Exp Hematol. 2001;5:201-221.
2. Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child. 2000;83:220-222.
3. Taub JW, Warrier I, Holtkamp C, et al. Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol. 1995;48:104-107.
4. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003;55:107-111.
5. Jubelirer SJ, Harpold R. The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review. Clin Appl Thromb Hemost. 2002;8:73-76.
6. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol. 1999;105:871-875.
7. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr. 1998;133:334-339.
8. Veys PA, Macey MG, Owens CM, et al. Neutropenia following intravenous immunoglobulin. Br Med J. 1988;296:1800.
9. Berkovitch M, Dolinski G, Tauber T, et al. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming. Int J Immunopharmacol. 1999;21:411-415.
10. Lassiter HA, Bibb KW, Bertolone SJ, et al. Neonatal immune neutropenia following the administration of intravenous immune globulin. Am J Pediatr Hematol Oncol. 1993;15:120-123.
11. Tam DA, Morton LD, Stroncek DF, et al. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol. 1996;64:175-178.
12. Anderson CL, Looney RJ. Human leucocyte IgG Fc receptors. Immunol Today. 1986;7:246.
13. Clarkson SB, Bussel JB, Kimberly RP, et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med. 1986;314:1236-1239.
14. Altznauer F, von Gunten S, Spath P, et al. Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J Allergy Clin Immunol. 2003;112:1185-1190.
15. Tsujimoto H, Takeshita S, Nakatani K, et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol. 2002;103:161-168.
16. Teeling JL, De Groot ER, Eerenberg AJ, et al. Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro. Clin Exp Immunol. 1998;114:264-270.
17. Matsuda M, Hosoda W, Sekijima Y, et al. Neutropenia as a complication of high-dose intravenous immunoglobulin therapy in adult patients with neuroimmunologic disorders. Clin Neuropharmacol. 2003;26:306-311.